.

NEWS

Lunan Pharma Valacyclovir Hydrochloride Tablets Passed the Consistency Evaluation

Time:2023-05-29 15:06:24     Views:169

New Media Department             Yu Jie, Duan Yuqing             May 29, 2023

Recently, Valacyclovir Hydrochloride Tablets of Shandong New Time Pharmaceutical Co., Ltd. has been approved by the National Medical Products Administration to increase the specification of this product to 0.5g. At the same time, this specification has passed the consistency evaluation of generic drug quality and efficacy, the approval number is: Guoyao Zhunzi H20237057.

This product is suitable for treating herpes zoster, herpes simplex virus infection, and preventing (inhibiting) the recurrence of herpes simplex virus infection. Valacyclovir is an antiviral agent and is the L-valine ester of acyclovir. Acyclovir is a purine (guanine) nucleoside analogue. Valacyclovir is almost completely rapidly converted into acyclovir and valine by the action of valacyclovir hydrolase in the human body. Acyclovir is a specific inhibitor of herpes virus, and has the ability to inhibit herpes simplex virus (HSV) types 1 and 2, varicella zoster virus (VZV), cytomegalovirus (CMV), Epstein-Barr virus (EBV) and the role of human herpesvirus 6 (HHV-6). After being phosphorylated into an active triphosphate form, acyclovir can inhibit the synthesis of viral DNA.


The young but global-oriented Lunan Pharmaceutical Group will achieve new, greater leap in revitalization of national medicine and creating an international century brand.
Copyright © 2022 Lunan Pharmaceutical Group All Rights Reserved.     Design By yunsu